Literature DB >> 19188549

Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure.

Joseph E Levitt1, Harmeet Bedi2, Carolyn S Calfee3, Michael K Gould4, Michael A Matthay3.   

Abstract

BACKGROUND: Despite being a focus of intensive investigation, acute lung injury (ALI) remains a major cause of morbidity and mortality. However, the current consensus definition impedes identification of patients with ALI before they require mechanical ventilation. To establish a definition of early ALI (EALI), we carried out a prospective cohort study to identify clinical predictors of progression to ALI.
METHODS: Potential cases of EALI were identified by daily screening of chest radiographs (CXRs) for all adult emergency department and new medicine service admissions at Stanford University Hospital.
RESULTS: Of 1,935 screened patients with abnormal CXRs, we enrolled 100 patients admitted with bilateral opacities present < 7 days and not due exclusively to left atrial hypertension. A total of 33 of these 100 patients progressed to ALI requiring mechanical ventilation during their hospitalization. Progression to ALI was associated with immunosuppression, the modified Rapid Emergency Medicine Score, airspace opacities beyond the bases, systemic inflammatory response syndrome, and the initial oxygen requirement (> 2 L/min). On multivariate analysis, only an initial oxygen requirement > 2 L/min predicted progression to ALI (odds ratio, 8.1; 95% confidence interval, 2.7 to 24.5). A clinical diagnosis of EALI, defined by hospital admission with bilateral opacities on CXR not exclusively due to left atrial hypertension and an initial oxygen requirement of > 2 L/min, was 73% sensitive and 79% specific for progression to ALI.
CONCLUSIONS: A new clinical definition of EALI may have value in identifying patients with ALI early in their disease course.

Entities:  

Mesh:

Year:  2009        PMID: 19188549      PMCID: PMC2758305          DOI: 10.1378/chest.08-2346

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  36 in total

1.  Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS.

Authors:  Todd W Rice; Arthur P Wheeler; Gordon R Bernard; Douglas L Hayden; David A Schoenfeld; Lorraine B Ware
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

2.  Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.

Authors:  C S Calfee; L B Ware; M D Eisner; P E Parsons; B T Thompson; N Wickersham; M A Matthay
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

3.  Randomized clinical trial of activated protein C for the treatment of acute lung injury.

Authors:  Kathleen D Liu; Joseph Levitt; Hanjing Zhuo; Richard H Kallet; Sandra Brady; Jay Steingrub; Mark Tidswell; Mark D Siegel; Graciela Soto; Michael W Peterson; Mark S Chesnutt; Charles Phillips; Ann Weinacker; B Taylor Thompson; Mark D Eisner; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2008-06-19       Impact factor: 21.405

4.  Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group.

Authors:  R C Bone; G Slotman; R Maunder; H Silverman; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

Review 5.  Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.

Authors:  Carolyn S Calfee; Mark D Eisner; Polly E Parsons; B Taylor Thompson; Edward R Conner; Michael A Matthay; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

6.  Toward early identification of acute lung injury in the emergency department.

Authors:  Robert J Freishtat; Bahar Mojgani; David J Mathison; James M Chamberlain
Journal:  J Investig Med       Date:  2007-12       Impact factor: 2.895

7.  Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.

Authors:  Lorraine B Ware; Michael A Matthay; Polly E Parsons; B Taylor Thompson; James L Januzzi; Mark D Eisner
Journal:  Crit Care Med       Date:  2007-08       Impact factor: 7.598

8.  Clinical risks for development of the acute respiratory distress syndrome.

Authors:  L D Hudson; J A Milberg; D Anardi; R J Maunder
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

9.  Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study.

Authors:  Niall D Ferguson; Fernando Frutos-Vivar; Andrés Esteban; Federico Gordo; Teresa Honrubia; Oscar Peñuelas; Alejandro Algora; Gema García; Alejandra Bustos; Inmaculada Rodríguez
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
View more
  42 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

Review 2.  Update on acute lung injury and critical care medicine 2009.

Authors:  Michael A Matthay; Steven Idell
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

3.  Clinical Characteristics and Outcomes Are Similar in ARDS Diagnosed by Oxygen Saturation/Fio2 Ratio Compared With Pao2/Fio2 Ratio.

Authors:  Wei Chen; David R Janz; Ciara M Shaver; Gordon R Bernard; Julie A Bastarache; Lorraine B Ware
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

4.  Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Ketong Zhu; Michael A Matthay; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2012-02-07       Impact factor: 5.191

Review 5.  Measurement of extravascular lung water using the single indicator method in patients: research and potential clinical value.

Authors:  Lisa M Brown; Kathleen D Liu; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-17       Impact factor: 5.464

Review 6.  Emerging therapies for the prevention of acute respiratory distress syndrome.

Authors:  Carl A Ruthman; Emir Festic
Journal:  Ther Adv Respir Dis       Date:  2015-05-22       Impact factor: 4.031

7.  Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study.

Authors:  Daryl J Kor; Ravi K Lingineni; Ognjen Gajic; Pauline K Park; James M Blum; Peter C Hou; J Jason Hoth; Harry L Anderson; Ednan K Bajwa; Raquel R Bartz; Adebola Adesanya; Emir Festic; Michelle N Gong; Rickey E Carter; Daniel S Talmor
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

8.  Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients.

Authors:  Daryl J Kor; Jason Erlich; Michelle N Gong; Michael Malinchoc; Rickey E Carter; Ognjen Gajic; Daniel S Talmor
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

Review 9.  The acute respiratory distress syndrome.

Authors:  Michael A Matthay; Lorraine B Ware; Guy A Zimmerman
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

10.  Prehospital aspirin use and acute respiratory distress syndrome--a case for aspirin in the drinking water?

Authors:  Jessica A Palakshappa; Jason D Christie
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.